Purchases and Sales Made in Q4 2023 in Regulus Therapeutics Inc. (RGLS)
This table provides information about the institutional ownership of Regulus Therapeutics Inc. (RGLS) during Q4 2023. The information is specifically focused on institutions that hold shares of Regulus Therapeutics Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Exome Asset Management LLC
New York, NY |
BUY
|
- |
178KNew |
$216K - $257K
|
178K
$293K
|
|
Feb 05, 2024
Q4 2023
|
Victory Capital Management Inc
|
BUY
|
- |
38.5K+ 16.52% |
$46.6K - $55.5K
|
272K
$446K
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
16.7K+ 142.94% |
$20.3K - $24.1K
|
28.5K
$46.7K
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
4.5K+ 8.98% |
$5.45K - $6.48K
|
54.6K
$89.5K
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
BUY
|
- |
2.12KNew |
$2.57K - $3.06K
|
2.12K
$3.48K
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
1.38K+ 0.48% |
$1.67K - $1.99K
|
286K
$470K
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
12+ 9.38% |
$14.5 - $17.3
|
140
$230
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
11New |
$13.3 - $15.8
|
11
$18
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
9+ 45.0% |
$10.9 - $13
|
29
$47.6
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-45- 7.28% |
$54.4 - $64.8
|
573
$940
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-64- 15.69% |
$77.4 - $92.2
|
344
$564
|
|
Jan 24, 2024
Q4 2023
|
Grimes & Company, Inc.
|
SELL
|
- |
-127- 1.2% |
$154 - $183
|
10.4K
$17.1K
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.57K- 99.53% |
$4.32K - $5.14K
|
17
$27.9
|